Global developmental delay
|
disease |
|
Mental or Behavioral Dysfunction
|
1825
|
553
|
0.310 |
strong |
< 0.001 |
1 |
|
2019 |
2019 |
AUTISM, SUSCEPTIBILITY TO, 15
|
disease |
|
Finding
|
9
|
3
|
0.300 |
strong |
1.000 |
1 |
|
2019 |
2019 |
Feeding difficulties
|
phenotype |
|
Finding
|
473
|
62
|
0.300 |
strong |
1.000 |
1 |
|
2019 |
2019 |
Generalized hypotonia
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Finding
|
955
|
164
|
0.300 |
strong |
1.000 |
1 |
|
2019 |
2019 |
Infarction
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Pathologic Function
|
15
|
|
0.200 |
None |
1.000 |
1 |
|
2012 |
2012 |
Testosterone measurement
|
phenotype |
|
Laboratory Procedure
|
14
|
23
|
0.100 |
None |
1.000 |
1 |
2
|
2019 |
2019 |
Central Nervous System Neoplasms
|
group |
Neoplasms; Nervous System Diseases
|
Neoplastic Process
|
180
|
72
|
0.100 |
None |
1.000 |
1 |
1
|
2015 |
2015 |
Sex hormone binding globulin measurement
|
phenotype |
|
Laboratory Procedure
|
11
|
21
|
0.100 |
None |
1.000 |
1 |
1
|
2008 |
2008 |
Finding of Mean Corpuscular Hemoglobin
|
phenotype |
|
Finding
|
653
|
1206
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Secondary malignant neoplasm of colon and/or rectum
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
397
|
68
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Glioma
|
disease |
Neoplasms
|
Neoplastic Process
|
3097
|
353
|
0.100 |
None |
1.000 |
1 |
1
|
2015 |
2015 |
Height
|
phenotype |
|
Organism Attribute
|
249
|
517
|
0.100 |
None |
1.000 |
1 |
1
|
2011 |
2011 |
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.070 |
None |
1.000 |
7 |
|
2002 |
2019 |
Primary malignant neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
8221
|
1374
|
0.030 |
None |
1.000 |
3 |
|
2009 |
2016 |
Malignant Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
8621
|
1641
|
0.030 |
None |
1.000 |
3 |
|
2009 |
2016 |
Meningioma
|
disease |
Neoplasms; Nervous System Diseases
|
Neoplastic Process
|
634
|
43
|
0.020 |
None |
1.000 |
2 |
|
2016 |
2018 |
Triple Negative Breast Neoplasms
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
1674
|
99
|
0.020 |
None |
1.000 |
2 |
|
2019 |
2019 |
Conventional (Clear Cell) Renal Cell Carcinoma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
2346
|
222
|
0.020 |
None |
1.000 |
2 |
|
2010 |
2011 |
Renal Cell Carcinoma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
2084
|
288
|
0.020 |
None |
1.000 |
2 |
|
2010 |
2011 |
Triple-Negative Breast Carcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
1598
|
96
|
0.020 |
None |
1.000 |
2 |
|
2019 |
2019 |
Carcinogenesis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6243
|
355
|
0.020 |
None |
1.000 |
2 |
1
|
2010 |
2012 |
Refractory Cytopenia of Childhood
|
disease |
|
Neoplastic Process
|
264
|
3
|
0.010 |
None |
1.000 |
1 |
|
2010 |
2010 |
Oxyphilic Adenoma
|
disease |
Neoplasms
|
Neoplastic Process
|
114
|
3
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Hormone refractory prostate cancer
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
683
|
29
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Malignant neoplasm of colon and/or rectum
|
disease |
|
Neoplastic Process
|
3669
|
502
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |